Skip to main content
search
 
 

DPP HIV-Syphilis receives CLIA Waiver: The First & Only FDA Approved, CLIA Waived* HIV-Syphilis Rapid Test

*CLIA Waived for fingerstick whole blood

Learn More
 

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

Learn More
 
 

Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK® Assay at Chembio Diagnostics Malaysia Facility

Learn More
1
1

Announcing the receipt of CLIA Waiver for DPP HIV-Syphilis. Contact your local Chembio Representative for more information

DPP® HIV-Syphilis

CLIA Waved Badge

Upcoming Events:

2024 SCASM Annual Meeting, Booth #207

October 4-5, 2024
Hyatt Regency La Jolla
La Jolla, CA

National Conference on Correctional Health Care 2024, Booth #325

October 19-23, 2024
Paris Hotel
Las Vegas, NV 89109​​​​​​​

Stay up to date with our latest news.

Chembio

Chembio Diagnostics Inc. receives a grant for Development of a DPP Congenital Syphilis Assay

Chembio Diagnostics Inc., a subsidiary of Biosynex, receives a grant  for Development of a DPP…
Bio Synex Logo
Chembio

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG,…
Chembio

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on…
About Us

We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.

Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate.

Our Core Values: “RAPID”

Relentless

Accountable

Passionate

Innovative

Diverse

Learn More

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.

Subscribe to the Chembio Mailing List